Published in Mol Cancer on December 23, 2009
Role of Notch and its oncogenic signaling crosstalk in breast cancer. Biochim Biophys Acta (2010) 1.50
Identifying cancer biomarkers by network-constrained support vector machines. BMC Syst Biol (2011) 1.14
Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog. BMC Cancer (2014) 1.09
Nicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivo. Proc Natl Acad Sci U S A (2012) 1.09
Cell cycle and aging, morphogenesis, and response to stimuli genes are individualized biomarkers of glioblastoma progression and survival. BMC Med Genomics (2011) 1.04
A double-edged sword: how oncogenes and tumor suppressor genes can contribute to chromosomal instability. Front Oncol (2013) 1.00
Notch signaling as a therapeutic target for breast cancer treatment? Breast Cancer Res (2011) 0.97
Claudin-1 regulates intestinal epithelial homeostasis through the modulation of Notch-signalling. Gut (2013) 0.92
The emerging importance of α-L-fucose in human breast cancer: a review. Am J Transl Res (2011) 0.89
Abrin immunotoxin: targeted cytotoxicity and intracellular trafficking pathway. PLoS One (2013) 0.88
Scribble modulates the MAPK/Fra1 pathway to disrupt luminal and ductal integrity and suppress tumour formation in the mammary gland. PLoS Genet (2014) 0.86
The role of Adams in Notch signaling. Adv Exp Med Biol (2012) 0.86
MicroRNA 199b-5p delivery through stable nucleic acid lipid particles (SNALPs) in tumorigenic cell lines. Naunyn Schmiedebergs Arch Pharmacol (2013) 0.85
Expression of Notch1 Correlates with Breast Cancer Progression and Prognosis. PLoS One (2015) 0.83
A role for Jag2 in promoting uveal melanoma dissemination and growth. Invest Ophthalmol Vis Sci (2013) 0.83
Effect of Trastuzumab on Notch-1 Signaling Pathway in Breast Cancer SK-BR3 Cells. Chin J Cancer Res (2012) 0.82
The MEK/ERK pathway promotes NOTCH signalling in pancreatic cancer cells. PLoS One (2013) 0.82
New targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancers. World J Clin Cases (2014) 0.82
Mutually exclusive mutations in NOTCH1 and PIK3CA associated with clinical prognosis and chemotherapy responses of esophageal squamous cell carcinoma in China. Oncotarget (2016) 0.82
Combining Notch inhibition with current therapies for breast cancer treatment. Ther Adv Med Oncol (2013) 0.81
Γ-secretase components as predictors of breast cancer outcome. PLoS One (2013) 0.80
HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer. J Steroid Biochem Mol Biol (2014) 0.80
High expression of Notch ligand Jagged2 is associated with the metastasis and recurrence in urothelial carcinoma of bladder. Int J Clin Exp Pathol (2013) 0.79
Cooperation of deregulated Notch signaling and Ras pathway in human hepatocarcinogenesis. J Mol Histol (2011) 0.79
A novel Monoclonal Antibody against Notch1 Targets Leukemia-associated Mutant Notch1 and Depletes Therapy Resistant Cancer Stem Cells in Solid Tumors. Sci Rep (2015) 0.78
Coordinate hyperactivation of Notch1 and Ras/MAPK pathways correlates with poor patient survival: novel therapeutic strategy for aggressive breast cancers. Mol Cancer Ther (2014) 0.78
Notch4 is required for tumor onset and perfusion. Vasc Cell (2013) 0.78
HGF/MET signaling promotes glioma growth via up-regulation of Cox-2 expression and PGE2 production. Int J Clin Exp Pathol (2015) 0.77
Pathway Relevance Ranking for Tumor Samples through Network-Based Data Integration. PLoS One (2015) 0.77
A Role for Notch Signalling in Breast Cancer and Endocrine Resistance. Stem Cells Int (2016) 0.76
Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis). J Clin Oncol (2017) 0.75
Over-expression of NOTCH1 as a biomarker for invasive breast ductal carcinoma. 3 Biotech (2016) 0.75
A gain-of-function germline mutation in Drosophila ras1 affects apoptosis and cell fate during development. PLoS One (2011) 0.75
Calcium-Oxidant Signaling Network Regulates AMP-activated Protein Kinase (AMPK) Activation upon Matrix Deprivation. J Biol Chem (2016) 0.75
Identification and characterization of a novel Sso7d scaffold-based binder against Notch1. Sci Rep (2017) 0.75
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
Stem cells, cancer, and cancer stem cells. Nature (2001) 50.27
Notch signaling: cell fate control and signal integration in development. Science (1999) 28.83
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev (2003) 20.77
Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science (2004) 18.84
Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer (2003) 15.17
Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res (2005) 11.52
Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev (2001) 11.25
Signalling downstream of activated mammalian Notch. Nature (1995) 11.08
TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell (1991) 10.06
Tissue repair and stem cell renewal in carcinogenesis. Nature (2004) 6.28
Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res (2004) 5.60
Notch signalling regulates stem cell numbers in vitro and in vivo. Nature (2006) 5.49
Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell (2003) 5.36
The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat Rev Cancer (2003) 4.75
High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res (2005) 4.61
Species- and cell type-specific requirements for cellular transformation. Cancer Cell (2004) 4.25
Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med (2002) 4.04
Aberrant activation of notch signaling in human breast cancer. Cancer Res (2006) 3.92
Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J Cell Biol (2004) 3.87
Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Res (2005) 3.63
Alterations in Notch signaling in neoplastic lesions of the human cervix. Proc Natl Acad Sci U S A (1995) 3.33
Mammary stem cells, self-renewal pathways, and carcinogenesis. Breast Cancer Res (2005) 3.05
Mammalian numb proteins promote Notch1 receptor ubiquitination and degradation of the Notch1 intracellular domain. J Biol Chem (2003) 2.94
The ins and outs of notch signaling. Mol Cell Neurosci (1997) 2.61
JAGGED1 expression is associated with prostate cancer metastasis and recurrence. Cancer Res (2004) 2.59
Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers. Cancer Res (2007) 2.54
Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches. Cancer Res (2008) 2.19
Impaired notch signaling promotes de novo squamous cell carcinoma formation. Cancer Res (2006) 2.02
NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells. Cancer Res (2008) 2.01
Ras activation in human breast cancer. Breast Cancer Res Treat (2000) 1.83
The love-hate relationship between Ras and Notch. Genes Dev (2005) 1.82
Notch signaling: the demise of elegant simplicity. Curr Opin Genet Dev (2004) 1.79
CSL-independent Notch signalling: a checkpoint in cell fate decisions during development? Curr Opin Genet Dev (2002) 1.68
Activated Notch1 signaling cooperates with papillomavirus oncogenes in transformation and generates resistance to apoptosis on matrix withdrawal through PKB/Akt. Virology (2001) 1.63
Signaling pathways in Ras-mediated tumorigenicity and metastasis. Proc Natl Acad Sci U S A (1998) 1.63
HER-2, notch, and breast cancer stem cells: targeting an axis of evil. Clin Cancer Res (2009) 1.59
The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions. J Gen Virol (1997) 1.51
Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells. Blood (2004) 1.43
Phenotypic and functional characterization of human mammary stem/progenitor cells in long term culture. PLoS One (2009) 1.33
Is there a role for Notch signalling in human breast cancer? Breast Cancer Res (2003) 1.21
Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias. APMIS (2007) 1.20
The cytotoxicity of gamma-secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by gamma-secretase inhibition. Breast Cancer Res (2009) 1.19
Notch signalling in cancer stem cells. Clin Transl Oncol (2009) 1.19
Coexpression of Notch1 and NF-kappaB signaling pathway components in human cervical cancer progression. Gynecol Oncol (2006) 1.18
Notch, Myc and breast cancer. Cell Cycle (2007) 1.16
Functional nuclear epidermal growth factor receptors in human choriocarcinoma JEG-3 cells and normal human placenta. Endocrinology (1995) 1.12
Breast cancer cells expressing stem cell markers CD44+ CD24 lo are eliminated by Numb-1 peptide-activated T cells. Cancer Immunol Immunother (2008) 1.10
Wnt pathway and breast cancer. Front Biosci (2007) 1.08
An Epstein-Barr virus protein interacts with Notch. J Virol (2001) 0.99
Reactive oxygen species regulate quiescent T-cell apoptosis via the BH3-only proapoptotic protein BIM. Cell Death Differ (2004) 0.93
Notch signaling and its integration with other signaling mechanisms. Regen Med (2006) 0.90
Unexpected features of acute T lymphoblastic lymphomas in Notch1IC transgenic rats. Eur J Immunol (2006) 0.80
Signaling pathways in early onset sporadic breast cancer of patients in Indonesia. Acta Med Indones (2008) 0.78
Retracted Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis. Cancer Cell (2003) 3.56
Notch signaling pathway as a therapeutic target in breast cancer. Mol Cancer Ther (2010) 1.39
Regulation of epithelial-mesenchymal and mesenchymal-epithelial transitions by microRNAs. Curr Opin Cell Biol (2013) 1.39
Phenotypic and functional characterization of human mammary stem/progenitor cells in long term culture. PLoS One (2009) 1.33
Simian virus 40 small T antigen activates AMPK and triggers autophagy to protect cancer cells from nutrient deprivation. J Virol (2009) 1.20
Evidence for a role for notch signaling in the cytokine-dependent survival of activated T cells. J Immunol (2006) 1.11
Intrapulmonary mature teratoma. Diagn Pathol (2006) 1.03
Dissecting the oncogenic and tumorigenic potential of differentiated human induced pluripotent stem cells and human embryonic stem cells. Cancer Res (2011) 1.02
A monoclonal antibody against human Notch1 ligand-binding domain depletes subpopulation of putative breast cancer stem-like cells. Mol Cancer Ther (2011) 1.00
SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome. Cancer Biol Ther (2010) 1.00
Quantitative tissue proteomics of esophageal squamous cell carcinoma for novel biomarker discovery. Cancer Biol Ther (2011) 0.99
miR-294/miR-302 promotes proliferation, suppresses G1-S restriction point, and inhibits ESC differentiation through separable mechanisms. Cell Rep (2013) 0.99
Costimulation-adhesion blockade is superior to cyclosporine A and prednisone immunosuppressive therapy for preventing rejection of differentiated human embryonic stem cells following transplantation. Stem Cells (2013) 0.95
Papillomavirus-mediated neoplastic progression is associated with reciprocal changes in JAGGED1 and manic fringe expression linked to notch activation. J Virol (2004) 0.93
Notch signaling in CD66+ cells drives the progression of human cervical cancers. Cancer Res (2011) 0.91
Sinus histiocytosis with nodal and extranodal involvement--a case report. J Indian Med Assoc (2003) 0.89
Cutaneous leiomyosarcoma, trichoblastoma, and syringocystadenoma papilliferum arising from nevus sebaceus. Int J Dermatol (2007) 0.88
SILAC-based quantitative proteomic analysis of gastric cancer secretome. Proteomics Clin Appl (2013) 0.87
Watching reprogramming in real time. Nat Biotechnol (2009) 0.87
Competing views on cancer. J Biosci (2014) 0.86
Identification of head and neck squamous cell carcinoma biomarker candidates through proteomic analysis of cancer cell secretome. Biochim Biophys Acta (2013) 0.86
Prevalence of high-risk human papillomavirus genotypes in retinoblastoma. Br J Ophthalmol (2011) 0.86
Identification of a novel AMPK-PEA15 axis in the anoikis-resistant growth of mammary cells. Breast Cancer Res (2014) 0.85
Plasmablastic lymphoma of the oral cavity in an HIV-positive child. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2005) 0.83
Antibodies against the extracellular domain of human Notch1 receptor reveal the critical role of epidermal-growth-factor-like repeats 25-26 in ligand binding and receptor activation. Biochem J (2013) 0.82
Overexpression of periostin and lumican in esophageal squamous cell carcinoma. Cancers (Basel) (2010) 0.80
Generation of induced pluripotent stem cells from the prairie vole. PLoS One (2012) 0.80
Evaluation of protein expression pattern of stanniocalcin 2, insulin-like growth factor-binding protein 7, inhibin beta A and four and a half LIM domains 1 in esophageal squamous cell carcinoma. Cancer Biomark (2013) 0.80
Maternal transmission of human papillomavirus in retinoblastoma: A possible route of transfer. Indian J Med Paediatr Oncol (2012) 0.78
Recapitulating tumour microenvironment in chitosan-gelatin three-dimensional scaffolds: an improved in vitro tumour model. J R Soc Interface (2012) 0.77
A network map of the gastrin signaling pathway. J Cell Commun Signal (2014) 0.77
The utility of second look microlaryngoscopy after trans oral laser resection of laryngeal cancer. Indian J Otolaryngol Head Neck Surg (2012) 0.75
Immunohistochemical analysis of CK 18 in dental follicles of impacted third molars: a pilot study. Indian J Dent Res (2013) 0.75
Childhood hepatic angiosarcoma--a case report. Indian J Pathol Microbiol (2005) 0.75
Ovarian hemangioma with stromal luteinization and HCG-producing mononucleate and multinucleate cells of uncertain histogenesis: a rare co-existence with therapeutic dilemma. Indian J Pathol Microbiol (2013) 0.75
Fetal rhabdomyoma of the lower extremity. Pediatr Blood Cancer (2009) 0.75
Corrigendum: A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma. Sci Rep (2017) 0.75
Primary synovial sarcoma of kidney-a report of 2 cases and review of literature. J Egypt Natl Canc Inst (2010) 0.75